Fenoksipropazin
Idi na navigaciju
Idi na pretragu
| |||
| (IUPAC) ime | |||
|---|---|---|---|
| (1-metil-2-fenoksi-etil)hidrazin | |||
| Klinički podaci | |||
| Identifikatori | |||
| CAS broj | 3818-37-9 | ||
| ATC kod | nije dodeljen | ||
| PubChem[1][2] | 71467 | ||
| ChemSpider[3] | 64548 | ||
| UNII | 8E92V52324 | ||
| ChEMBL[4] | CHEMBL1909286 | ||
| Hemijski podaci | |||
| Formula | C9H14N2O | ||
| Mol. masa | 166,22 g/mol} | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | ℞ Prescription only | ||
| Način primene | Oralno | ||
Fenoksipropazin (prodajno ime Drazin) je ireverzibilni i neselektivni inhibitor monoaminoksidaze (MAOI) iz hidrazinske hemijske klase. On je uveden u upotrebu kao antidepresiv 1961, ali je naknadno povućen sa tržišta 1966. zbog moguće pojave hepatotoksičnosti.[5][6][7][8][9]
Vidi još[uredi - уреди | uredi izvor]
Reference[uredi - уреди | uredi izvor]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). "PubChem as a public resource for drug discovery.". Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). "Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities". Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). "Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining". J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. http://www.jcheminf.com/content/2/1/3.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). "ChEMBL: a large-scale bioactivity database for drug discovery". Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.
- ↑ LEAHY MR, ROSE JT, PLOWMAN R (April 1963). "A preliminary study of phenoxypropazine in the treatment of depression". The American Journal of Psychiatry 119: 986–7. PMID 13928824. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=13928824.
- ↑ IMLAH NW (May 1963). "Preliminary report on phenoxypropazine". The American Journal of Psychiatry 119: 1091–2. PMID 13956423. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=13956423.
- ↑ ROSE JT, LEAHY MR, PLOWMAN R (October 1963). "A comparison of phenoxypropazine and amitriptyline in depression". The American Journal of Psychiatry 120: 393–5. PMID 14069469. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=14069469.
- ↑ ROSE JT (March 1964). "Phenoxypropazine and chlordiazepoxide in depression". The American Journal of Psychiatry 120: 899–900. PMID 14129290. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=14129290.
- ↑ MCWHINNEY IR, MORRELL DC (January 1965). "Treatment of mild endogenous depression with a monoamine oxidase inhibitor: a controlled trial in general practice". The Journal of the College of General Practitioners 9: 95–9. PMC 1878242. PMID 14254271. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1878242/.
Spoljašnje veze[uredi - уреди | uredi izvor]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||